Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial ...

Neurizon Therapeutics Limited, a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases, announced that the Bellberry Human Research Ethics Committee ...

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has received ...

Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s pivotal phase 3 study (CBL-0301 phase 3) for subcutaneous fat ...

Psyence BioMed has received formal approval from the Bellberry Human Research Ethics Committee (HREC), Australia, to use psychedelic active pharmaceutical ingredient (API) developer, PsyLabs’ ...

The Bellberry application is a key regulatory milestone, advancing Adze's commitment to initiating clinical studies of its immunotherapy candidate, Adze1.C, Submitting the Bellberry HREC application ...

Bellberry is a leading independent ethics committee certified by the National Health and Medical Research Council (NHMRC) with the approval allowing LTR Pharma (ASX:LTP) to move forward with patient ...

Adze Biotech, develops systemically-deliverable oncolytic immunotherapies, received Bellberry HREC approval for Phase I clinical trial in metastatic melanoma. This approval validates the robustness of ...

Bellberry HREC approves Neurizon’s Phase 1 formulation study of NUZ-001 oral liquid, supporting continued development of ALS program Study to enrol 32 healthy volunteers assessing oral liquid and ...